BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35446373)

  • 1. De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring.
    Moulis G; Crickx E; Thomas L; Massy N; Mahévas M; Valnet-Rabier MB; Atzenhoffer M; Michel M; Godeau B; Bagheri H; Salvo F;
    Blood; 2022 Apr; 139(16):2561-2565. PubMed ID: 35446373
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.
    Chanut M; Jaidi R; Kohn M; Grange T; Brones C; Lombion N; Rousselot P; Longval T
    Platelets; 2022 May; 33(4):652-653. PubMed ID: 35225144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute immune thrombocytopenia following SARS-CoV-2 vaccination in chronic ITP patients and a healthy individual.
    Ogai A; Yoshida R; Yuasa C; Chin K; Fujimaki K; Nakajima H
    Int J Hematol; 2022 Feb; 115(2):293-295. PubMed ID: 34716890
    [No Abstract]   [Full Text] [Related]  

  • 4. SARS-CoV-2 Vaccination: Long-Term Follow-Up of Pre-existing and De Novo Immune Thrombocytopenia.
    Beltrami Moreira M; Bussel JB; Lee EJ
    Thromb Haemost; 2023 Apr; 123(4):482-486. PubMed ID: 36539200
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine.
    Tarawneh O; Tarawneh H
    Am J Hematol; 2021 May; 96(5):E133-E134. PubMed ID: 33476455
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune thrombocytopenic purpura after SARS-CoV-2 vaccine.
    Candelli M; Rossi E; Valletta F; De Stefano V; Franceschi F
    Br J Haematol; 2021 Aug; 194(3):547-549. PubMed ID: 33934330
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune thrombocytopenia following SARS-CoV-2 vaccination in a female: Report of one case.
    Lee ZM; Chen YC; Liu SC; Wang CC
    Pediatr Blood Cancer; 2023 May; 70(5):e30211. PubMed ID: 36726145
    [No Abstract]   [Full Text] [Related]  

  • 8. Vincristine therapy for severe and refractory immune thrombocytopenia following COVID-19 vaccination.
    Saito K; Ichikawa S; Hatta S; Katsuoka Y; Harigae H; Izumi T
    Ann Hematol; 2022 Apr; 101(4):885-887. PubMed ID: 34599382
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.
    Ganzel C; Ben-Chetrit E
    Isr Med Assoc J; 2021 Jun; 23(6):341. PubMed ID: 34155844
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune Thrombocytopenic Purpura (ITP) Triggered by COVID-19 Infection and Vaccination.
    David P; Dotan A; Mahroum N; Shoenfeld Y
    Isr Med Assoc J; 2021 Jun; 23(6):378-380. PubMed ID: 34155853
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know.
    Arepally GM; Ortel TL
    Blood; 2021 Jul; 138(4):293-298. PubMed ID: 34323940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: SARS-CoV-2 mRNA Vaccines and the Possible Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT).
    Parums DV
    Med Sci Monit; 2021 Apr; 27():e932899. PubMed ID: 33900279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unilateral linear purpuric rash heralding SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia.
    Hung YT; Huang YL; Chang YY; Chen WT
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e429-e431. PubMed ID: 35176191
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune thrombocytopenia following COVID-19 mRNA vaccine: casuality or causality?
    Pasin F; Calabrese A; Pelagatti L
    Intern Emerg Med; 2022 Jan; 17(1):295-297. PubMed ID: 34100214
    [No Abstract]   [Full Text] [Related]  

  • 15. Correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS-CoV-2 vaccine.
    Scanvion Q; Lambert M; Hachulla E; Terriou L
    Br J Haematol; 2021 Sep; 194(6):e93-e95. PubMed ID: 34114220
    [No Abstract]   [Full Text] [Related]  

  • 16. VITT with inactivated SARS-CoV-2 vaccine - index case.
    Devi K; Ali N; Nasir N; Mahmood SF
    Hum Vaccin Immunother; 2022 Dec; 18(1):2036556. PubMed ID: 35254213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Thrombocytopenia Following COVID-19 Vaccination.
    Isaac S; Pasha MA; Yadav U
    Intern Med; 2022 Sep; 61(18):2827. PubMed ID: 35831105
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS-CoV-2 vaccine.
    De Stefano V; Candelli M; Rossi E; Franceschi F
    Br J Haematol; 2021 Sep; 194(6):e95-e96. PubMed ID: 34170008
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH.
    Oldenburg J; Klamroth R; Langer F; Albisetti M; von Auer C; Ay C; Korte W; Scharf RE; Pötzsch B; Greinacher A
    Hamostaseologie; 2021 Jun; 41(3):184-189. PubMed ID: 33822348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia.
    Favaloro EJ
    Int J Lab Hematol; 2021 Aug; 43(4):559-570. PubMed ID: 34138513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.